# HPV self-testing with same-day treatment as the national cervical programme

Source: https://onco.cc/ideas/idea-acc-hpv-self-sample-same-day-ablation/  
OnCo record `idea-acc-hpv-self-sample-same-day-ablation` (Idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Women can collect their own sample for the virus that causes cervical cancer; those who test positive can be treated the same day with a simple heat device. Done nationally, this could eliminate a disease that still kills hundreds of thousands of women a year.

## Summary

WHO's cervical cancer elimination strategy sets 70% screening coverage with a high-performance test and 90% treatment of pre-cancer. Self-collected HPV testing removes the speculum exam that deters women, and portable thermal ablation allows treatment at the point of screening without histology. Point-of-care HPV tests now return results within an hour. The proposal is to make this combination, rather than cytology, the default national programme and fund it as a vertical campaign.

## Fields

- Kind: Idea
- Last checked: 2026-09-08
- Hypothesis: Countries implementing self-sampling plus same-day ablation will reach 70% screening coverage of women aged 35-45 within five years, versus under 20% for cytology-based programmes, and will halve pre-cancer treatment loss to follow-up.
- Rationale: Self-sampling roughly doubles participation in trials in Africa and Latin America; screen-and-treat eliminates the second visit that loses most patients.
- Proposed test: National rollout with population coverage, positivity, same-day treatment rate, and cervical cancer incidence tracked in the population-based registry over ten years.
- Maturity: being-tested-at-scale
- Actor: policy

## Sources

- WHO cervical cancer elimination initiative: https://www.who.int/initiatives/cervical-cancer-elimination-initiative

## Connected records

- cancers: [Cervical cancer](https://onco.cc/cancers/cervical/)
- fronts: [Prevention & Risk](https://onco.cc/fronts/prevention/)
- technologies: [HPV & HBV vaccination](https://onco.cc/technologies/hpv-vaccine/), [Visual inspection with acetic acid (VIA) for cervical screening](https://onco.cc/technologies/via-cervical-screening/)
- bottlenecks: [Most of the world has almost no cancer care](https://onco.cc/bottlenecks/b-global-access/), [Prevention we already have is not deployed](https://onco.cc/bottlenecks/b-prevention-adoption/)
- key papers: [Self-collected HPV samples are as accurate as clinician samples and reach women who never attend screening](https://onco.cc/key-papers/paper-hpv-self-sampling-bmj-2018/)
- roadmaps: [Devices and physical therapies roadmap: heat and light → electric fields and focused sound → drug-releasing implants](https://onco.cc/roadmaps/devices-roadmap/), [Global access and affordability roadmap: essential medicines and generics → biosimilars and frugal trials → reliance, pooling and homegrown innovation](https://onco.cc/roadmaps/global-access-roadmap/)

---
JSON: https://onco.cc/api/v1/entities/idea-acc-hpv-self-sample-same-day-ablation.json